John Ruedy serves as Executive at BIOJECT MEDICAL TECHNOLOGIES INC, where they oversee executive responsibilities. Since joining the company, John Ruedy has executed 8 insider transactions totaling $18.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 5, 2009 involved exercising options for 19,000 shares valued at $0.
John Ruedy currently holds 104,810 shares of BIOJECT MEDICAL TECHNOLOGIES INC (BJCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Ruedy has been a net buyer of BJCT stock. They have purchased $18.4K and sold $0 worth of shares.
John Ruedy's most recent insider trade was on Jun 5, 2009, when they sold 19,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 19,000 |
| $N/A |
| Discretionary |
| Jun 14, 2008 | BJCT | $0 | Option Exercise | 11,000 | $N/A | Discretionary |
| Dec 14, 2007 | BJCT | $0 | Option Exercise | 11,000 | $N/A | Discretionary |
| Dec 14, 2007 | BJCT | $0 | Option Exercise | 11,000 | $N/A | Discretionary |
| May 24, 2007 | BJCT | $0 | Option Exercise | 5,250 | $N/A | Discretionary |
| Nov 27, 2006 | BJCT | $0 | Option Exercise | 5,250 | $N/A | Discretionary |
| Jun 15, 2006 | BJCT | $18.4K | Purchase | 15,000 | $1.23 | Discretionary |